Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence of Donor-Derived Hematologic Malignancies after Hematopoietic Stem Cell Transplantation

24 Apr 2006

Abstract excerpt

Increasing the upper age limit for recipients of hematopoietic stem cell transplantation (HCT) naturally has also increased the age of the corresponding related donor population. Because aging is a risk factor for malignancies, the risk of transferring preexisting malignant or premalignant hemopoietic clones in the process of HCT might be expected to increase as well. Anecdotal clinical cases of malignancies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Acute Myeloid Leukemia Research
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16635786
DOI: 10.1016/j.bbmt.2006.01.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence of Donor-Derived Hematologic Malignancies after Hematopoietic Stem Cell TransplantationPMID 16635786Read ↗

A case report of donor cell-derived hematologic neoplasms 9 years after allogeneic hematopoietic cell transplantation.Semantic proximity Read ↗

Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some AnswersSemantic proximity Read ↗

Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantationSemantic proximity Read ↗

Young and Restless: Expansion of Donor-Origin Mutant HSCs after Transplantation.Semantic proximity Read ↗

Solid cancers after allogeneic hematopoietic cell transplantationSemantic proximity Read ↗

Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent EraSemantic proximity Read ↗

Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipientSemantic proximity Read ↗

Donor Cell Leukemia: A ReviewSemantic proximity Read ↗

Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantationSemantic proximity Read ↗

Multiple donor-derived leukemias in a recipient of allogeneic hematopoietic cell transplantation for myeloid malignancySemantic proximity Read ↗

Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.